Endpoint: Second Esophagus Cancer Overall RR
1
2
Relative Risk (95% CI) IV Random
RR ES (95 CI%); Weight %
Studies, number of pt.
Overall number of studies:
Total number of Patients:
Second Esophagus cancers:
Treatment years:
Range of FU:
4
413,650
386
1961 to 2007
0.6 to 26 years
0.5
4
RT
39%
NON-RT
61%
RT decreased risk
RT
increased
risk
Roychounduri 2004
Zablotska 2005,
Mastectomy
Zablotska 2005,
BCS
Grantzau 2012
TOTAL; I
2
= 11%
1.23 (0.75-2.01)
25
Schaapveld 2008,
>50 y
Schaapveld 2008,
<50 y
(61,782)
(43,390)
(46,176)
(61,442)
(183,182)
0.93 (0.46-1.87)
14
1.86 (1.11-3.11)
24
0.64 (0.16-2.48)
4
0.85 (0.49-1.48)
21
1.17 (0.89-1.54) 100
1.17 (0.56-2.44)
13
(14,678)